semaglutide for animals Ozempic dogs' may be the next big thing in pet health Semaglutide | GLP-1 Receptor Agonist

Obesity is linked to a laundry list of additional health problems, and those problems become costly for Virginia's $25 billion a year Medicaid program

Past controversies, present confidence GLP-1 medications have had a chequered past when it comes to mood

More research is needed to understand the unique benefits (and potential pitfalls) of peer support for bipolar disorder, the researchers conclude

Transparency: We do not claim that compounded medications are FDA-approved in the same way branded drugs are

Also in 2025, Yang & colleagues alleged, Patients with obesity and OSA may consider GLP-1 RA as a potential treatment option if the adverse effects are deemed tolerable. Expert-Guided, Sustainable Weight Loss Discover how GLP-1 medications, combined with expert support, can help you reach lasting weight loss results